Evidence map›Paper›PMID 24975032›Full record

ArticleEuropean journal of immunology2014

Insertional hypermutation in mineral oil-induced plasmacytomas.

Gero Knittel, Mirjam Metzner, Gabriele Beck-Engeser, Ada Kan, Tomasz Ahrends, Dan Eilat, Konrad Huppi, Matthias Wabl

Open access · greenAbstract read
In one paragraph

Article in European journal of immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Complement C3d enables cell-mediated immunity capable of distinguishing spontaneously transformed from nontransformed cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  2. Inbred Mouse Models inJournal of fungi (Basel, Switzerland) · 2024
    Review
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Gero KnittelDepartment of Microbiology and Immunology, University of California, San Francisco, CA, USA.
Mirjam Metzner
Gabriele Beck-Engeser
Ada Kan
Tomasz Ahrends
Dan Eilat
Konrad Huppi
Matthias Wabl
University of California, San Francisco · USHadassah Academic College · ILNational Cancer Institute · US

Funding

GENE TARGETED MICE WITH A SIMPLIFIED IMMUNE SYSTEMR01AI041570 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WABL, MATTHIAS R · 1998 to 2014
$4.6M
GENE TARGETED MICE WITH A SIMPLIFIED IMMUNE SYSTEMR21AI041570 · NIAID · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI WABL, MATTHIAS R · 1997 to 1997
–
NIAID NIH HHS R01 AI041570NIAID NIH HHS R01AI041570NIAID NIH HHS R21 AI041570
6 · The paper itself

Abstract

Unless stimulated by a chronic inflammatory agent, such as mineral oil, plasma cell tumors are rare in young BALB/c mice. This raises the questions: What do inflammatory tissues provide to promote mutagenesis? And what is the nature of mutagenesis? We determined that mineral oil-induced plasmacytomas produce large amounts of endogenous retroelements--ecotropic and polytropic murine leukemia virus and intracisternal A particles. Therefore, plasmacytoma formation might occur, in part, by de novo insertion of these retroelements, induced or helped by the inflammation. We recovered up to ten de novo insertions in a single plasmacytoma, mostly in genes with common retroviral integration sites. Additional integrations accompany tumor evolution from a solid tumor through several generations in cell culture. The high frequency of de novo integrations into cancer genes suggests that endogenous retroelements are coresponsible for plasmacytoma formation and progression in BALB/c mice.

Indexed as

Mutagenesis, InsertionalNeoplasms, ExperimentalPlasmacytomaRetroelementsAnimalsCell LineEmollientsMiceMice, Inbred BALB CMineral OilEmollientsMineral OilRetroelementsEndogenous retroelementsInflammationMutagenesisPlasmacytomasTumor evolution

Identifiers

PMID24975032
PMCPMC4165787
OpenAlexW1925722892

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.